PNS Pharma

PNS Pharma is a leading provider of pharmaceutical reports that comprise extensive data, latest technologies, company and product profiles and many more.

Every research activity supposes holistic analysis and promotion of the drugs available at the market along with introduction of ongoing products with the detailed description of a manufacturing process chain. Thus, the clients obtain the following data and characteristics of the drug investigated:
  • an original inventor;
  • chemical formula;
  • patent information;
  • licensing;
  • owner;
  • stage of development according related to the sales territory.
PNS Pharma’s research activity covers the most diverse treatment medications including diabetes and endocrinology, respiratory and immunology, ophthalmology, oncology, infectious diseases, etc.

PNS Pharma has gained a big recognition due to its syndicated reports that together with a complex drug expertize perform company pipeline analysis. This enables to trace all the pharmaceuticals produced, monitor various therapeutic aspects and geographical areas where this product is used or developed.


Research Reports By PNS Pharma

Found 49 publications
Global Monoclonal Antibodies Pipeline Insight 2015 US$ 2,400.00 Mar, 2015 1600 pages
Global Peptide Therapeutics Pipeline Insight 2015 US$ 2,400.00 Feb, 2015 1200 pages
Small Molecule Cancer Drug Clinical Pipeline Insight US$ 2,400.00 Jan, 2015 1650 pages
Global Orphan Drug Pipeline & Regulatory Insight 2015 US$ 3,300.00 Jan, 2015 2200 pages
Subcutaneous Drug Delivery Market & Pipeline Insight US$ 2,400.00 Jan, 2015 1800 pages
US Orphan Drug Clinical Pipeline Insight 2014 US$ 2,000.00 Aug, 2014 2000 pages
US CNS Disorders Drug Pipeline Insight 2014 US$ 2,400.00 Aug, 2014 1700 pages
Schizophrenia Drug Market & Pipeline Insight US$ 1,200.00 Jun, 2014 386 pages
Cervical Cancer Drug Market & Pipeline Insight US$ 1,800.00 Jun, 2014 165 pages
Cancer Cytokines Therapy Pipeline Analysis US$ 1,800.00 Jun, 2014 231 pages
Crohn’s Disease Drug Market and Pipeline Analysis US$ 1,800.00 May, 2014 297 pages
Global Peptide Therapeutics Market & Pipeline Insight US$ 2,400.00 Feb, 2014 1350 pages
US Cancer Vaccine Pipeline Analysis US$ 1,500.00 Jan, 2014 300 pages
Japan Cancer Drug Pipeline Analysis US$ 1,500.00 Jan, 2014 557 pages
Europe Alzheimer's Disease Drug Pipeline Analysis US$ 1,500.00 Jan, 2014 265 pages
US Skin Cancer Drug Pipeline Analysis US$ 1,200.00 Jan, 2014 310 pages
Global Vaccine Market Pipeline Analysis US$ 1,500.00 Jan, 2014 1150 pages
Europe Parkinson’s Disease Drug Pipeline Analysis US$ 1,000.00 Jan, 2014 199 pages
Europe Orphan Drug Pipeline Analysis 2014 US$ 2,400.00 Jan, 2014 1430 pages
Global Monoclonal Antibodies Pipeline Analysis US$ 1,800.00 Jan, 2014 1360 pages
Europe Lung Cancer Drug Pipeline Analysis US$ 1,200.00 Jan, 2014 340 pages
US Colorectal Cancer Drug Pipeline Analysis US$ 1,500.00 Nov, 2013 242 pages
US Lung Cancer Drug Pipeline Analysis US$ 1,800.00 Nov, 2013 385 pages
US Parkinson's Disease Drug Pipeline Analysis US$ 1,500.00 Nov, 2013 241 pages
Global Oncolytic Virus Therapy Pipeline Analysis US$ 1,500.00 Oct, 2013 105 pages
US Alzheimer Drug Pipeline Analysis US$ 2,000.00 Oct, 2013 348 pages
US Orphan Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 880 pages
Global HIV Infection Drug Pipeline Analysis US$ 1,500.00 Oct, 2013 300 pages
Global DNA Vaccine Pipeline Analysis US$ 1,500.00 Oct, 2013 130 pages
Europe Breast Cancer Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 380 pages
Orphan Drugs for Cancer Pipeline Analysis US$ 1,800.00 Oct, 2013 855 pages
Global RNAi Drug Pipeline Analysis US$ 1,500.00 Oct, 2013 250 pages
US Breast Cancer Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 480 pages
Global Infertility Drug Pipeline Analysis US$ 1,000.00 Oct, 2013 60 pages
US Prostate Cancer Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 375 pages
Global Cancer Vaccines Pipeline Analysis US$ 1,800.00 Sep, 2013 345 pages
Gene Therapy Drug Pipeline Analysis US$ 1,500.00 Sep, 2013 185 pages
Global Cell Therapy Pipeline Analysis US$ 1,500.00 Sep, 2013 220 pages
Malaria Disease Drug Pipeline Analysis US$ 1,200.00 Aug, 2013 185 pages
Hepatitis C Drug Pipeline Analysis US$ 1,800.00 Aug, 2013 700 pages
Pancreatic Cancer Drug Pipeline Analysis US$ 1,800.00 Aug, 2013 515 pages
Ovarian Cancer Pipeline Analysis US$ 1,800.00 Aug, 2013 660 pages
Skip to top

Analytics, News & Press-Releases by PNS Pharma